Display options
Cite
Martin-Macintosh EL, Broski SM, Johnson GB, et al. Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR Am J Roentgenol. 2016;207(4):883-895doi: 10.2214/AJR.14.12910.
Martin-Macintosh, E. L., Broski, S. M., Johnson, G. B., Hunt, C. H., Cullen, E. L., & Peller, P. J. (2016). Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR. American journal of roentgenology, 207(4), 883-895. https://doi.org/10.2214/AJR.14.12910
Martin-Macintosh, Erica L, et al. "Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias." AJR. American journal of roentgenology vol. 207,4 (2016): 883-895. doi: https://doi.org/10.2214/AJR.14.12910
Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR Am J Roentgenol. 2016 Oct;207(4):883-895. doi: 10.2214/AJR.14.12910. Epub 2016 Aug 09. PMID: 27504528.
Copy Download .nbib Format: NLM
Share it on

AJR Am J Roentgenol. 2016 Oct;207(4):883-895. doi: 10.2214/AJR.14.12910. Epub 2016 Aug 09.

Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias.

AJR. American journal of roentgenology

Erica L Martin-Macintosh, Stephen M Broski, Geoffrey B Johnson, Christopher H Hunt, Ethany L Cullen, Patrick J Peller

Affiliations

  1. 1 Department of Radiology, Division of Nuclear Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
  2. 2 Department of Radiology, Division of Neuroradiology, Mayo Clinic, Rochester, MN.
  3. 3 Eka Medical Center Jakarta, Bumi Serpong Damai City, Tangerang, Indonesia.

PMID: 27504528 DOI: 10.2214/AJR.14.12910

Abstract

OBJECTIVE: The purpose of this article is to describe the role of multimodality imaging in the evaluation of atypical neurodegenerative conditions. An imaging approach to the more common dementia disease processes was described in part 1. This article, part 2, briefly discusses current Centers for Medicare & Medicaid Services coverage for imaging patients with dementia and illustrates the basic concepts of combining anatomic, metabolic, and amyloid imaging in the evaluation of patients with atypical neurodegenerative dementia. Although these disease processes are rare, the growing repertoire of clinically available imaging techniques necessitates an understanding of their imaging patterns.

CONCLUSION: Despite the rarity of these conditions, imaging of patients with neurodegenerative disorders is on the rise, and familiarity with the imaging appearances of these atypical causes is increasingly important.

Keywords: brain; dementia; molecular imaging; neurodegenerative

Publication Types